Associated Papers
CRISPR targeting of FOXL2 c.402C>G mutation reduces malignant phenotype in granulosa tumor cells and identifies anti-tumoral compounds.
Amarilla-Quintana S et al.
Molecular Oncology, 2025
39776254 (PubMed )
Supplement: MOL2-19-1092-s005.pdf
Select a paper to view details